Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0344232 (blurred vision)
 2,072 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The authors have studied the effects of precurarisation by means of pancuronium on 120 female patients by using three multiple doses of pancuronium bromide. The authors have demonstrated that the dose of pancuronium, capable of abolishing almost completely fasciculations and postoperative succinylcholine myalgias, corresponds to 0.009 mg/kg. This dose has proved to be most efficient in causing a considerable increase in subjective precurarisation symptoms (Heavy eye-lids, blurred vision etc.). Such symptoms have never caused even the least discomfort to the patients. The authors have finally demonstrated that the doses of pancuronium employed cause a decrease in V.C. within limits that do not, however, compromise ventilation.
 ...
PMID:Pancuronium bromide precurarisation. II An evaluation of clinical aspects in patients of female sex. 48 87

The authors specified, briefly, the different subgroups and prevalence of the molecules from the quinolone family: Nalidixic acid (synthesised in 1958), the quinolones of second generation (oxilinic acid, piromidique, pipemidique and flumequine) and the quinolones of third generation (ciprofloxacine, norfloxacine, ofloxacine, perfloxacine). After having mentioned the extent and the importance of using these antibiotics in infections, they stressed the fact that the quinolones are antibiotics which are largely prescribed in clinics and hospitals. The authors reported afterwards the observation of a young female, without any precedent neuropsychiatric disorders having shown a complex clinical state with neurological and psychiatric disturbances during the first day of treatment for a urinary infection with 4 tablets of flumequine 400 mg per day (instead of 3 recommended). Mrs. A. 25 years of age was seen to during the night at The "Consultation Psychiatrique d'Orientation et d'Accueil" (C.P.O.A.). of Sainte-Anne hospital by the resident psychiatric of a General Hospital "after behavioural disturbances". In fact, about 3 hours before and 15 minutes after the third dose of flumequine (2 tablets of 400 mg), this makes the total dose taken over 12 hours is equal to 400 x 4 = 1,600 mg, the patient developed an intense discomfort with blurred vision accompanied by nausea, followed by a state of restlessness and incomprehensible speech. A testimony by relatives revealed that she suffered, shortly afterwards, a generalised fit which affected her 4 limbs with a fixation of her eyes and hypersalivation and convulsions without either swallowing the tongue or involuntary urination.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Neuropsychiatric manifestations and quinolones. Apropos of a case]. 166 73

We evaluated the visual results and success rate with a center-near concentric simultaneous vision bifocal contact lens. Forty subjects (screened from 175 presbyopic applicants) entered the study and were fitted with the CIBA Spectrum bifocal lenses (BCL) and also with single vision distance contact lenses combined with reading glasses (DCL). Visual acuity and stereoacuity measurements were made at dispensing and after 8 weeks of regular bifocal contact lens wear. At both times, visual acuity measurements with BCL were significantly reduced by 1-1.5 lines compared to DCL. Stereoacuity was reduced by 32-36" with BCL compared to DCL. Thirty-two patients completed the study and 27 chose to continue wearing BCL after completion of the study. None of the subjects had adverse corneal findings or problems of discomfort. The primary reason for BCL discontinuation was blurred vision. The data was retrospectively analyzed to identify risk factors for discontinuance--none were significant.
 ...
PMID:Patient response to concentric bifocal contact lenses. 181 35

Evidence from controlled clinical trials of oximes indicates that high doses given im or iv may cause transient disturbances of vision. Blurring of vision and diplopia present for up to an hour can occur. These are often accompanied by other side effects such as nausea, epigastric discomfort, drowsiness and dizziness. Visual effects have not been reported following high doses of oximes given po. Experimental studies provide evidence that some oximes given at high dosages may penetrate the blood-brain and blood-aqueous humor barriers. These suggest that the visual effects may be mediated through the CNS and/or by direct effects on the accommodation mechanisms of the eye. Although transient, the visual effects should be taken into account in clinical trials designed to assess the dosage necessary to achieve prophylaxis against OP antiChE poisoning in occupational situations.
 ...
PMID:Ophthalmic effects of oximes: a review. 203 43

An epidemiological survey on 30,000VDT operators has been carried out to evaluate the relationship between asthenopia and monitor characteristics. A VDU operator has been classified as asthenopeic if he complained about at least two of the following ten symptoms: headache, tearing, eye smarting, blurred vision, double vision, ocular itching, photophobia, blinking, nausea, eye heaviness. Visual discomfort has been related to 1) the presence of flicker; the possibility to regulate, 2) brightness, 3) height; and 4) inclination of monitor. Asthenopia has resulted statistically correlated to the presence of flicker and to the impossibility of regulating height and inclination of monitor for both sexes. The possibility to regulate monitor brightness has not determined a reduction of visual discomfort either in men or in women.
 ...
PMID:[Asthenopia and monitor characteristics]. 208 58

Artificial tears, commonly prescribed for correction of the dry-eye syndrome, are formulated with suitably preserved aqueous polymeric solutions to promote corneal wetting without causing such side-effects as burning, itching, blurred vision and scratchiness. Four of the most commonly used commercial tear-replacement solutions were investigated after complaints of irritation by some users. The solutions were tested for tonicity, viscosity and pH and found to be in the tolerable range (tonicity equivalent to 0.5-1.5% m/v sodium chloride, viscosity 1-15 centipoise and pH 4-9). A double-blind cross-over study was conducted on 16 subjects and the degree of discomfort (non-irritant, irritant, and highly irritant) was determined subjectively. Results indicated that 3 of the tear solutions were acceptable. However, over 50% of the subjects reported irritation from the solution comprising polyvinyl alcohol 1.4% m/v preserved with 0.5% m/v chlorobutanol. To identify the cause of irritation, two extemporaneously prepared controls containing polyvinyl alcohol 1.4% m/v, with and without chlorobutanol 0.5% m/v as preservative, were also included in the study. The irritant response was found to be caused by the presence of chlorobutanol in the formulation. An attempt is made to identify and explain formulation properties likely to elicit adverse responses.
 ...
PMID:Irritation associated with tear-replacement ophthalmic drops. A pharmaceutical and subjective investigation. 264 9

Twenty persons with chronic low back pain participated in a clinical study to evaluate the effects of gravity traction. Each subject was instructed in the use of three devices, two for inversion and one for upright suspension traction. Baseline pulse and rate blood pressure were recorded before and after traction. Periods of traction did not exceed 20 minutes. The order of use of the devices was randomized. Each participant was monitored for significant side effects and was questioned to determine which device was best tolerated, easiest to use, or caused changes in back symptoms. Lateral lumbar spine radiographs were taken with the subject in the standing position and after varying periods of inversion. Observations included the following: An average increase in blood pressure of 17.2 systolic (range 4-34) and 16.4 diastolic (range 2-50) while in the inverted position. An average decrease in heart rate of 16.4 beats per minute (range, 4-32). No significant physiologic changes of blood pressure or pulse were observed in patients using GLR suspension traction; distraction of the lower lumbar intervertebral spaces (range, 0.3 to 4.0 mm) with inverted traction in all cases; side effects including periorbital and pharyngeal petechiae (one patient), persistent headaches (three patients), persistent blurred vision (three patients), and contact lense discomfort (one patient); and improvement of low back symptoms in 13 of the 16 symptomatic patients. Although these devices make lumbar traction practical in a home setting, their use should be under medical supervision because of possible side effects.
 ...
PMID:Inversion devices: their role in producing lumbar distraction. 315 39

The need for surgical repair of monocanalicular lacerations is controversial. The authors used temporary punctal plugs of hydroxypropyl cellulose to assess the symptoms associated with upper and lower monocanalicular obstruction in 18 normal eyes. Fifty percent of those experimental obstructions resulted in mild intermittent symptoms of epiphora, increased tear film, discomfort, or blurred vision. Constant epiphora was not reported. The results suggest that a single upper or lower canaliculus is sufficient for drainage of minimally stimulated tear secretion but may not completely drain reflex tear secretion. This information may help patients and ophthalmologists reach an informed decision as to the need for surgical repair of a severed canaliculus.
 ...
PMID:Symptoms of canalicular obstruction. 323 45

The safety of orthokeratological (OK) procedures was assessed by monitoring several ocular characteristics including corneal thickness, refractive astigmatism, corneal astigmatism, correctable spectacle-acuity, corneal edema, corneal staining, and endothelial cell density. Safety was also assessed by reviewing the number and causes of extra clinical visits that occurred because of ocular complications and by determining whether safety factors were related to patients lost to follow-up. Over the 1.2-year period from the baseline examination to the end of the lens-wearing phase of the study, the Treatment (T) and Control (C) groups had, respectively, only small changes in their mean levels of corneal thickness (0.2 vs. 3.2 microns), refractive astigmatism (0.07 vs 0.01 D), and corrected spectacle acuity (0.02 vs 0.018 logarithm of the minimum angle of resolution). Analysis of time trend data obtained from scheduled monthly examinations also showed that changes in mean corneal thickness and mean corneal astigmatism were small and not clinically important in either comparison group during the course of the treatment. As a result of complications from lens wear, the T group required 1.25 times as many extra visits as the C group (p = 0.14). However, none of these visits provided sufficient clinical indication for the discontinuance of lens wear. Loss to follow-up typically occurred because of either poor compliance with the study protocol or loss of motivation caused by minor contact lens-related symptoms such as blurred vision, slight discomfort, or frequently lost lenses. These reasons were similar in both comparison groups. It appears that OK treatment is safe for the types of patients who participated in this study, but it may require more patient monitoring than would be needed to achieve and maintain a physiologically acceptable fit with conventional hard contact lens prescriptions.
 ...
PMID:The Berkeley Orthokeratology Study, part III: safety. 634 45

Complications from mydriatic and cycloplegic drugs are rare compared with their extensive use. Adverse effects are often related to dosage or other factors. The ocular complications include increased intraocular pressure, pigmentation of the conjunctiva and cornea, pigment in the anterior chamber, lacrimal duct blockage, macular edema, corneal endothelium damage, hyperemia, allergy, discomfort, and blurred vision. The systemic complications are those common to sympathomimetic and parasympatholytic drugs and include tachycardia, hypertension, headache, faintness. pallor, trembling, excessive sweating, palpitations, arrhythmias, confusion, hallucinations, drowsiness, ataxia, flushed skin, high fever, dysarthria, thirst, dry mouth, convulsions, disorientation, nervousness, coma, and death. An understanding of all possible side effects is of paramount importance to those using these drugs in the treatment of anticholinesterase poisoning. This review is intended as a ready reference to the adverse effects of mydriatic and cycloplegic drugs.
 ...
PMID:Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. 703 29


1 2 3 4 5 Next >>